239 results
8-K
EX-99.1
CYTK
Cytokinetics Inc
27 Feb 24
Cytokinetics Reports Fourth Quarter 2023 Financial Results
4:05pm
no instances of worsening heart failure or treatment interruptions due to low left ventricular ejection fraction (LVEF).
Presented new long-term data … million, net, raised in early 2024 through our ATM equity vehicle, our year end cash balance of $655.4 million, plus available long-term debt from
8-K
EX-99.1
CYTK
Cytokinetics Inc
2 Nov 23
Cytokinetics Reports Third Quarter 2023 Financial Results
4:05pm
of Aficamten in Obstructive HCM,
in Late December
Long-Term Data from FOREST-HCM,
the Open-Label Extension Study of Aficamten,
Show Sustained Improvements … trial of aficamten in obstructive hypertrophic cardiomyopathy (HCM), at the HCM Society Scientific Sessions 2023.
Shared new long-term data from FOREST
8-K
EX-99.1
wdp6vc8bh4yrztrt yn
19 Oct 23
Regulation FD Disclosure
7:32am
8-K
pnkmy6hlvipm22zjm
6 Oct 23
Other Events
4:32pm
8-K
EX-99
7tuekbk
3 Aug 23
Cytokinetics Reports Second Quarter 2023 Financial Results
4:00pm
8-K
EX-99.1
pu9l7qoyu782ncdvj7n
22 May 23
Other Events
6:43pm
8-K
EX-99.1
eivsi1g
4 May 23
Cytokinetics Reports First Quarter 2023 Financial Results
4:03pm
8-K
didbv
7 Nov 22
Other Events
7:30am
8-K
EX-99.1
sxlpml81j92 7fdm
3 Nov 22
Cytokinetics Reports Third Quarter 2022 Financial Results
4:06pm
8-K
jo8qzin7v0y0
3 Oct 22
Other Events
9:00am
8-K
7gn2xc
30 Sep 22
Other Events
4:30pm
8-K
EX-99.1
dddovi3r
4 Aug 22
Cytokinetics Reports Second Quarter 2022 Financial Results
4:03pm